BUY Dixon Technologies (India) Ltd. — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Intraday)19 Aug 2026, 12:22 pm ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Q1 Earnings: Nuvama Upgrades Amara Raja, Sharda Cropchem; Cuts Titan, Dixon Tech — Full List, Target Price
NewsNdtv-Profit·18 Aug · yesterday
Dixon Tech Issues $220 Million Guarantee To Lenovo For Arm Padget Electronics
NewsNdtv-Profit·14 Aug · 4d ago
Dixon Technologies (India) Limited proposes to incorporate a new subsidiary company.
BSE · Company Update·12 Aug · 6d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dixon Technologies (India)
- SELL — Nagaraj Shetty, HDFC Securities21 Oct 2026 · ~3 months · target ₹10,950 · Active
- BUY — Arun Kumar Mantri14 Oct 2026 · ~2 weeks · target ₹13,125 · SL hit
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · Same day · target ₹13,150 · SL hit
- SELL — Somil Mehta, Sharekhan5 Oct 2026 · ~2 weeks · target ₹12,000 · Expired
- BUY — Swati Hotkar, Nirmal Bang Securities29 Sept 2026 · ~3 months · target ₹14,500 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

